These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1457283

  • 1. Connective tissue metabolism including cytokines in scleroderma.
    Smith EA.
    Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
    [Abstract] [Full Text] [Related]

  • 2. Activation of dermal connective tissue in scleroderma.
    Kähäri VM.
    Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
    [Abstract] [Full Text] [Related]

  • 3. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 4. Cytokines and human fibrosis.
    LeRoy EC, Trojanowska MI, Smith EA.
    Eur Cytokine Netw; 1990 May; 1(4):215-9. PubMed ID: 1966552
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M.
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [Abstract] [Full Text] [Related]

  • 7. Production of fibrogenic cytokines by interleukin-2-treated peripheral blood leukocytes: expression of transforming growth factor-beta and platelet-derived growth factor B chain genes.
    Kovacs EJ, Brock B, Silber IE, Neuman JE.
    Obstet Gynecol; 1993 Jul; 82(1):29-36. PubMed ID: 8515922
    [Abstract] [Full Text] [Related]

  • 8. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 9. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM.
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of systemic scleroderma: immunological aspects].
    Mouthon L, García De La Peña-Lefebvre P, Chanseaud Y, Tamby MC, Boissier MC, Guillevin L.
    Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
    [Abstract] [Full Text] [Related]

  • 12. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y, Smith EA, LeRoy EC, Trojanowska M.
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunological modulation of dermal fibroblasts in scleroderma.
    Perlish JS, Fleischmajer R.
    Immunol Ser; 1989 Jan; 46():605-24. PubMed ID: 2488871
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM.
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M.
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM.
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
    Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K.
    Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.